2024 Partners
Asymchem
Your Trusted CDMO Pharmaceutical Partner.
Our solutions range from early clinical stage to commercial stage, including R&D and cGMP production of advanced intermediates, APIs, formulations, as well as clinical research services. Through strategic partnerships and calculated business growth, we have built an integrated service ecosystem.
For more information visit www.asymchem.com
Precision Antibody
Precision Antibody, a global leader in custom antibody development generates monoclonal and polyclonal antibodies against wide variety of targets in 60 days. We develop royalty-free, fully human monoclonal therapeutic antibodies tailored to your needs in 60 days. We deliver antibodies that work in your intended assay. We develop anti-idiotype antibodies for PK and ADA assays and offer preclinical in vitro and in vivo assays. Precision Antibdy delivers solutions to your unmet antibody development needs.
For more information visit: www.precisionantibody.com
CogNano
CogNano is a pioneering biotechnology company that develops innovative antibody-based therapies for refractory cancers. Utilizing our proprietary AI-driven drug discovery platform, we are committed to rapidly providing new cancer-specific antigen information to facilitate the development of targeted therapies. Our mission is to revolutionize cancer treatment by providing safe, effective, and cost-efficient solutions. CogNano is dedicated to accelerating the advancement and commercialization of next-generation cancer therapies.
For more information visit: www.cognanous.com
